Market Overview

XTL Biopharma Buys Stake in Proteologics from Teva

Share:
Related TEVA
Watch These 8 Huge Call Purchases In Wednesday Trade
Benzinga's Option Alert Recap From April 25
Bridge Creek Capital Management LLC Buys Boeing Co, General Motors Co, Teva Pharmaceutical ... (GuruFocus)

XTL Biopharmaceuticals Ltd. announced on November 21^st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium). The Shares represent all of Teva's shares in Proteologics and represent approximately 31.35% of Proteologics issued and outstanding share capital.

Posted-In: News Asset Sales

 

Related Articles (TEVA)

View Comments and Join the Discussion!